Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA.
Pediatr Neonatol. 2010 Jun;51(3):143-8. doi: 10.1016/S1875-9572(10)60027-7.
Neonatal jaundice can be best understood as a balance between the production and elimination of bilirubin, with a multitude of factors and conditions affecting each of these processes. When an imbalance results because of an increase in circulating bilirubin (or the bilirubin load) to significantly high levels (severe hyperbilirubinemia), it may cause permanent neurologic sequelae (kernicterus). In most infants, an increase in bilirubin production (e.g., due to hemolysis) is the primary cause of severe hyperbilirubinemia, and thus reducing bilirubin production is a rational approach for its management. The situation can become critical in infants with an associated impaired bilirubin elimination mechanism as a result of a genetic deficiency and/or polymorphism. Combining information about bilirubin production and genetic information about bilirubin elimination with the tracking of bilirubin levels means that a relative assessment of jaundice risk might be feasible. Information on the level of bilirubin production and its rate of elimination may help to guide the clinical management of neonatal jaundice.
新生儿黄疸可被视为胆红素生成和消除之间的平衡,许多因素和情况会影响这两个过程。当由于循环胆红素(或胆红素负荷)增加到显著高水平(严重高胆红素血症)而导致失衡时,可能会导致永久性神经后遗症(核黄疸)。在大多数婴儿中,胆红素生成增加(例如,由于溶血)是严重高胆红素血症的主要原因,因此减少胆红素生成是管理该病的合理方法。当由于遗传缺陷和/或多态性导致相关的胆红素消除机制受损时,情况可能会变得危急。将胆红素生成信息与胆红素消除的遗传信息以及胆红素水平的跟踪相结合,意味着可能可以对黄疸风险进行相对评估。胆红素生成水平及其消除率的信息可能有助于指导新生儿黄疸的临床管理。